While managing diabetes, when you eat is just as important as what you eat. 

Researchers at the University of Toronto have developed a test to determine which patients who experience gestational diabetes are most at risk for future type 2 diabetes. 

Danish study makes strong recommendations for diabetes pharmacotherapy beyond metformin. 

Lower percentages of lean body mass have shown correlation to a higher risk of diabetes in older men.

Body mass in adolescence affects risk of developing type 2 as an adult. 

Imeglimin, a new, first-in-class blood-glucose-lowering agent, proves to be safe and efficient as monotherapy and adjunctive therapy to lower A1C in patients with type 2 diabetes. 

A large UK study investigates which patients may be likely to discontinue metformin therapy. 

Study shows that visit-to-visit HbA1C variability can have significant effects on the prognosis for patients living with diabetes.

Study of BMI and ESRD suggests obesity may provide a health benefit when it comes to end-stage renal disease.

Prolonged lactation may reduce the risk for women with a history of gestational diabetes.